MDGL Madrigal Pharmaceuticals

Healthcare Biotechnology

Latest news and analysis for Madrigal Pharmaceuticals (MDGL).

2 articles | Category: Healthcare

Current Price

$432.00 -13.85 (-3.11%)

Market data may be delayed

Price Chart

Loading chart...

Healthcare | MDGL | 4d ago

MDGL's advancements in retinal disease therapeutics could be a game-changer. Discover how these developments shape the company's future.

Healthcare | MDGL | 5d ago

MDGL faces shifting dynamics as Kymera Therapeutics announces advances in protein degradation therapies that could impact its market position.